1 / 12

WP 9-10 GRACE GCP

WP 9-10 GRACE GCP. G ood C linical P ractice (GCP) WP9-10 14 September 2007 Stockholm. WP 9-10 GRACE GCP. GCP  Two basic goals: 1. Ensuring the integrity/quality of data - Documentation (e.g. protocol, audit trail) - Source/study documents to be stored for 15 years

kuper
Télécharger la présentation

WP 9-10 GRACE GCP

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. WP 9-10 GRACEGCP Good Clinical Practice (GCP) WP9-10 14 September 2007 Stockholm

  2. WP 9-10 GRACEGCP GCP  Two basic goals: 1. Ensuring the integrity/quality of data - Documentation (e.g. protocol, audit trail) - Source/study documents to be stored for 15 years 2. Protection of the rights of patients participating in trials - Approval of Ethical Committee (EC) - Qualified investigators - Informed consent procedure

  3. WP 9-10 GRACEGCP • Examples of standard GCP procedures: • Approval of Ethical Committee (EC) • Approval of national competent authority (CA) for WP10 (study with medicinal product) • Approval other regulatory authorities • Patient insurance to be obtained within each network • Informed consent procedure

  4. WP 9-10 GRACEDrug accountability • Drug logistics: • Manufacturer  pharmacist  NNF Practice  GP • First shipment: • 34 boxes per network • Each box containing 10 medication bottles (randomized) • Checks after receipt: • Supplies must be checked against shipment form • Box: network name and number correct • Arrival at practice: Check trial medication codes of the bottles inside (Always complete boxes are allocated to a practice) • Packaging/bottles should be intact

  5. WP 9-10 GRACEDrug accountability • Documentation: • Sign & date for receipt • Fax copy to sponsor and file original form in Site File • Hand out of study medication by GP: • Sequentially, see study medication code:112591,112628,112665, etc • Explain correct use • Explain correct storage • Explain unblinding procedure • Empty bottles/unused medication should be returned at visit 2 • Medication handed out & quantity returned should be documented on the Drug Accountability Log > faxed to NNF every month > data entry into GOS • - Start study medication after all samples are collected • Storage conditions: • Do not store above 30˚C. Protect from light and excessive humidity. • Please keep trial medication in a locked cabinet.

  6. WP 9-10 GRACEUnblinding • Unblinding: • When? In case the GP or another treating physician needs to know whether the GRACE patient got an antibiotic or placebo. • How? To break the code they can contact the 24 hour unblinding service by telephone*. The following questions will be asked: • 1. Are you a GP involved in GRACE or another treating physician • 2. Date of birth patient • 3. Trial medication code* • 4. Reason for unblinding • After that the code will be broken without any further restrictions • * See label on medication bottle

  7. WP 9-10 GRACESAE • SAE=serious adverse event • SAE classification: • Death • Life-threatening • In-patient hospitalisation • Disability/incapacity • Congenital anomaly/birth defect • Other medical events requiring intervention to prevent one of the outcomes listed above • In case of a SAE, the SAE form (in Site File) should be completed (study number handwritten) on the GRACE platform within 24 hours by GP or NNF* ! • * After fax and telephone call from GP

  8. WP 9-10 GRACEGRACE short questionnaire • No return of diary after about 4 weeks • However, it’s very important (>80%) to collect the most relevant data: • Symptoms first 3 days after consult/inclusion • Duration of illness • Study medication: yes or no • Side effects (diarrhoea, nausea, skin rash): yes or no • Reconsultation health service (GP, specialist, emergency department etc) • Send shortQ with letter (approved by EC) to patient • Or complete shortQ by telephone

  9. WP 9-10 GRACEMonitoring • According to the WP10 protocol: • GPs will be visited by monitors independent from GRACE* to perform source data verification of a randomly selected part of the patients/data. During these visits also the Site Files could be checked >> SOP in preparation • Also the presence of all signed consent forms will be verified. • Procedure: After inclusion a copy of the signed informed consent will be faxed together with the registration form to the NNF, so monitoring can take place. • * To be organized locally by the networks

  10. WP 9-10 GRACEOther GCP needs & SOPs • Slightly modified (if needed at all) GRACE-01 working practices will and can be used for WP9 & 10 also. For example: • GP surgery visit checklist • Signature list and delegation of responsibilities log • Training registration document • Signed & dated CVs from all participating GPs (NEW!) • GP & Network Site File • Screening logs • The Telephone Conversation SOP

  11. WP 9-10 GRACEAmendment • Old exclusion criterion: allergic to penicillin • New exclusion criterion: allergic to penicillin or have a contra-indication for amoxicillin because of a major interaction with other medication •  New version of WP10 protocol & patient CRF needed

More Related